Prion protein scrapie and the normal cellular prion protein

REFERENCES

• Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519-50; PMID:11283320; http://dx.doi.org/10.1146/annurev.neuro.24.1.519
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci 1998; 95:13363-13383; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363
   PubMed Web of Science ®Google Scholar
• Jeffrey M, Gonzalez L. Classical sheep transmissible spongiform encephalopathies: pathogenesis, pathological phenotypes and clinical disease. Neuropathol Appl Neurobiol 2007; 33(4):373-94; PMID:17617870; http://dx.doi.org/10.1111/j.1365-2990.2007.00868.x
   PubMed Web of Science ®Google Scholar
• Imran M, Mahmood S. An overview of animal prion diseases. Virol J 2011; 8:493; PMID:22044871; http://dx.doi.org/10.1186/1743-422X-8-493
   PubMed Web of Science ®Google Scholar
• Fields BN, Knipe DM, Howley PM. Virology: Third edition. 3rd ed. New York: Lippincott-Laven Publishers; 1996.
   Google Scholar
• Sigurdsson B, Rida A. Chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics. Br Vet J 1954; 110:341-54.
   Google Scholar
• DeArmon S, Bouzamondo E. Fundamentals of prion biology and diseases. Toxicology 2002; 181-182:9-16; PMID:12505278; http://dx.doi.org/10.1016/S0300-483X(02)00249-4
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-144; PMID:6801762; http://dx.doi.org/10.1126/science.6801762
   PubMed Web of Science ®Google Scholar
• Sparkes RS, Simon M, Cohn VH, Fournier R, Lem J, Klisak I, Heinzmann C, Blatt C, Lucero M, Mohandas T, et al. Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci 1986; 83:7358-7362; PMID:3094007; http://dx.doi.org/10.1073/pnas.83.19.7358
   PubMed Web of Science ®Google Scholar
• Meyer R, McKinley M, Bowman K, Braunfeld M, Barry R, Prusiner S. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci 1986; 83:2310-2314; PMID:3085093; http://dx.doi.org/10.1073/pnas.83.8.2310
   PubMed Web of Science ®Google Scholar
• Kim J, Cali, Surewicz I, Kong K, Raymond Q, Atarashi G, Race R, Qing B, Gambetti L, Caughey P, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 2010; 285(19):14083-7; PMID:20304915; http://dx.doi.org/10.1074/jbc.C110.113464
   PubMed Web of Science ®Google Scholar
• Sassa Y, Kataoka N, Inoshima Y, Ishiguro N. Anti-PrP antibodies detected at terminal stage of prion-affected mouse. Cell Immunol 2010; 263(2):212-218; PMID:20417929; http://dx.doi.org/10.1016/j.cellimm.2010.03.018
   PubMed Web of Science ®Google Scholar
• Pan K, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci 1993; 90:10962-10966; PMID:7902575; http://dx.doi.org/10.1073/pnas.90.23.10962
   PubMed Web of Science ®Google Scholar
• Benetti F, Legname G. De novo mammalian prion synthesis. Prion 2009; 3(4):213-9; PMID:19887900; http://dx.doi.org/10.4161/pri.3.4.10181
   PubMed Web of Science ®Google Scholar
• Prusiner S, McKinley M, Bowman K, Bolton D, Bendheim P, Groth D, Glenner G. Scrapie prions aggregate to form amyloid-like birefringentrods. Cell Immunol 1983; 35:349-358.
   Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337-348; PMID:9590169; http://dx.doi.org/10.1016/S0092-8674(00)81163-0
   PubMed Web of Science ®Google Scholar
• Kaneko K, Zulianello L, Scott M, Copper C, Wallace A, James T, Cohen F, Prusiner S. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci 1997; 94:10069-10074; PMID:9294164; http://dx.doi.org/10.1073/pnas.94.19.10069
   PubMed Web of Science ®Google Scholar
• Telling G, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen F, DeArmond S, Prusiner S. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83(1):79-90; PMID:7553876; http://dx.doi.org/10.1016/0092-8674(95)90236-8
   PubMed Web of Science ®Google Scholar
• Ghetti B, Piccardo P, Frangione B, Bugiani O, Giaccone G, Young K, Prelli F, Farlow M, Dlouhy S, Tagliavini F. Prion protein amyloidosis. Brain Pathol 1996; 6(2):127-145; PMID:8737929; http://dx.doi.org/10.1111/j.1750-3639.1996.tb00796.x
   PubMed Web of Science ®Google Scholar
• Scott MR, Will R, Ironside J, Nguyen H-O, Tremblay P, DeArmond S, Prusiner S. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci 1996; 96:15137-15142; http://dx.doi.org/10.1073/pnas.96.26.15137
   Web of Science ®Google Scholar
• Will RG, Alpers MP, Dormont D, Schonberger LB, Tateishi J. Infectious and sporadic prion diseases. in Prion Biology and Diseases. S.B. Prusiner, Editor. Cold Spring Harbor Laboratory Press: Cold Spring Harbor; 1999. pp. 465-507.
   Google Scholar
• Spocter MA, Hopkins WD, Barks SK, Bianchi S, Hehmeyer AE, Anderson SM, Stimpson CD, Fobbs AJ, Hof PR, Sherwood CC. Neuropil distribution in the cerebral cortex differs between humans and chimpanzees. J Comp Neurol 2012; 520(13):2917-29; PMID:22350926; http://dx.doi.org/10.1002/cne.23074
   PubMed Web of Science ®Google Scholar
• Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, Uphill JB, Goldstein D, Alpers M, Fisher EM, et al. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 2003; 300(5619):640-3; PMID:12690204; http://dx.doi.org/10.1126/science.1083320
   PubMed Web of Science ®Google Scholar
• Heath CA, Barker RA, Esmonde TF, Harvey P, Roberts R, Trend P, Head MW, Smith C, Bell JE, Ironside JW, et al. Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK. J Neurol Neurosurg Psychiatry 2006; 77(7):880-2; PMID:16627534; http://dx.doi.org/10.1136/jnnp.2005.073395
   PubMed Web of Science ®Google Scholar
• Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ, Alpers MP. Kuru in the 21st century–an acquired human prion disease with very long incubation periods. Lancet 2006; 367(9528):2068-74; PMID:16798390; http://dx.doi.org/10.1016/S0140-6736(06)68930-7
   PubMed Web of Science ®Google Scholar
• Houston F, McCutcheon S, Goldmann W, Chong A, Foster J, Sisó S, González L, Jeffrey M, Hunter N. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008; 112(12):4739-4745; PMID:18647958; http://dx.doi.org/10.1182/blood-2008-04-152520
   PubMed Web of Science ®Google Scholar
• Huang FP, MacPherson GG. Dendritic cells and oral transmission of prion diseases. Adv Drug Deliv Rev 2004; 56(6):901-13; PMID:15063597; http://dx.doi.org/10.1016/j.addr.2003.09.006
   PubMed Web of Science ®Google Scholar
• Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347(9006):921-5; PMID:8598754; http://dx.doi.org/10.1016/S0140-6736(96)91412-9
   PubMed Web of Science ®Google Scholar
• Ironside JW, McCardle L, Horsburgh A, Lim Z, Head MW. Pathological diagnosis of variant Creutzfeldt-Jakob disease. Apmis 2002; 110(1):79-87; PMID:12064259; http://dx.doi.org/10.1034/j.1600-0463.2002.100110.x
   PubMed Web of Science ®Google Scholar
• Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389(6650):498-501; PMID:9333239; http://dx.doi.org/10.1038/39057
   PubMed Web of Science ®Google Scholar
• Ward HJT, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, Heath C, Knight RS, Smith PG, Will RG. Risk factors for variant Creutzfeldt-Jakob disease: A case-control study. Ann Neurol 2006; 59(1):111-120; PMID:16287153; http://dx.doi.org/10.1002/ana.20708
   PubMed Web of Science ®Google Scholar
• Turner ML, Ironside JW. New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion. Blood Rev 1998; 12(4):255-268; PMID:9950096; http://dx.doi.org/10.1016/S0268-960X(98)90007-8
   PubMed Web of Science ®Google Scholar
• Gibbs CJ Jr., Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC. Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 1994; 57(6):757-8; PMID:8006664; http://dx.doi.org/10.1136/jnnp.57.6.757
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Sakai K, Noguchi-Shinohara M, Nozaki I, Takumi I, Sanjo N, Sadakane A, Nakamura Y, Kitamoto T, Saito N, et al. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. J Neurol Neurosurg Psychiatry 2013; 84(10):1171-5; PMID:23595947; http://dx.doi.org/10.1136/jnnp-2012-304850
   PubMed Web of Science ®Google Scholar
• Davidson LR, Llewelyn CA, Mackenzie JM, Hewitt PE, Will RG. Variant CJD and blood transfusion: are there additional cases? Vox Sang 2014; 107(3):220-5; PMID:24916465; http://dx.doi.org/10.1111/vox.12161
   PubMed Web of Science ®Google Scholar
• Billette de Villemeur T, Gelot A, Deslys JP, Dormont D, Duyckaerts C, Jardin L, Denni J, Robain O. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study. Neuropathol Appl Neurobiol 1994; 20(2):111-7; PMID:8072642; http://dx.doi.org/10.1111/j.1365-2990.1994.tb01169.x
   PubMed Web of Science ®Google Scholar
• Delisle MB, Fabre N, Rochiccioli P, Doerr-Schott J, Rumeau JL, Bes A. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study]. Rev Neurol (Paris) 1993; 149(10):524-7; PMID:8023064
   PubMed Web of Science ®Google Scholar
• Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974; 290(12):692-3; PMID:4591849
   PubMed Web of Science ®Google Scholar
• Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006; 67(3):389-93; PMID:16855204; http://dx.doi.org/10.1212/01.wnl.0000231528.65069.3f
   PubMed Web of Science ®Google Scholar
• Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG, Ladogana A, Pocchiari M, Leschek EW, Schonberger LB. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 2012; 18(6):901-7; PMID:22607808; http://dx.doi.org/10.3201/eid1806.120116
   PubMed Web of Science ®Google Scholar
• Palmer CM. A week that shook the meat industry: The effects on the UK beef industry of the BSE crisis. Br Food J 1996; 98(11):17-25; http://dx.doi.org/10.1108/00070709610153650
   Google Scholar
• Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: Molecular insights and diagnosis. Lancet Neurol 2012; 11(7):618-628; PMID:22710755; http://dx.doi.org/10.1016/S1474-4422(12)70063-7
   PubMed Web of Science ®Google Scholar
• Ben-Gedalya T, Cohen E. Quality control compartments coming of age. Traffic 2012; 13(5):635-642; PMID:22280095; http://dx.doi.org/10.1111/j.1600-0854.2012.01330.x
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, et al. Genetic prion disease: the EUROCJD experience. Hum Genet 2005; 118(2):166-174; PMID:16187142; http://dx.doi.org/10.1007/s00439-005-0020-1
   PubMed Web of Science ®Google Scholar
• Webb TEF, Poulter M, Beck J, Uphill J, Adamson G, Campbell T, Linehan J, Powell C, Brandner S, Pal S, et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 2008; 131:2632-2646; PMID:18757886; http://dx.doi.org/10.1093/brain/awn202
   PubMed Web of Science ®Google Scholar
• Arata H, Takashima H, Hirano R, Tomimitsu H, Machigashira K, Izumi K, Kikuno M, Ng AR, Umehara F, Arisato T, et al. Early clinical signs and imaging findings in Gerstmann-Straussler-Scheinker syndrome (Pro102Leu). Neurology 2006; 66(11):1672-1678; PMID:16769939; http://dx.doi.org/10.1212/01.wnl.0000218211.85675.18
   PubMed Web of Science ®Google Scholar
• Yamada M, Tomimitsu H, Yokota T, Tomi H, Sunohara N, Mukoyama M, Itoh Y, Suematsu N, Otomo E, Okeda R, et al. Involvement of the spinal posterior horn in Gerstmann-Straussler-Scheinker disease (PrP P102L). Neurology 1999; 52(2):260-265; PMID:9932941; http://dx.doi.org/10.1212/WNL.52.2.260
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene - Phenotypic spectrum. J Neurol 2002; 249(11):1567-1582; PMID:12420099; http://dx.doi.org/10.1007/s00415-002-0896-9
   PubMed Web of Science ®Google Scholar
• Kretzschmar HA, Kufer P, Riethmüller G, DeArmond S, Prusiner SB, Schiffer D. Prion protein mutation at Codon-102 in an Italian family with gerstmann-straussler-scheinker syndrome. Neurology 1992; 42(4):809-810; PMID:1348851; http://dx.doi.org/10.1212/WNL.42.4.809
   PubMed Web of Science ®Google Scholar
• Rowe DB, Lewis V, Needham M, Rodriguez M, Boyd A, McLean C, Roberts H, Masters CL, Collins SJ. Novel prion protein gene mutation presenting with subacute PSP-like syndrome. Neurology 2007; 68(11):868-870; PMID:17353478; http://dx.doi.org/10.1212/01.wnl.0000256819.61531.98
   PubMed Web of Science ®Google Scholar
• Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB. Linkage of a Prion Protein Missense Variant to Gerstmann-Straussler Syndrome. Nature 1989; 338(6213):342-345; PMID:2564168; http://dx.doi.org/10.1038/338342a0
   PubMed Web of Science ®Google Scholar
• Kretzschmar HA, Honold G, Seitelberger F, Feucht M, Wessely P, Mehraein P, Budka H. Prion Protein Mutation in Family 1st Reported by Gerstmann, Straussler, and Scheinker. Lancet 1991; 337(8750):1160-1160; PMID:1674033; http://dx.doi.org/10.1016/0140-6736(91)92826-N
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Calella AM. Prions: Protein aggregation and infectious diseases. Physiol Rev 2009; 89(4):1105-1152; PMID:19789378; http://dx.doi.org/10.1152/physrev.00006.2009
   PubMed Web of Science ®Google Scholar
• Montagnese F, Barca E, Musumeci O, Mondello S, Migliorato A, Ciranni A, Rodolico C, De Filippi P, Danesino C, Toscano A. Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): Unusual features and response to treatment. J Neurol 2015; 262(4):968-978; PMID:25673129; http://dx.doi.org/10.1007/s00415-015-7664-0
   PubMed Web of Science ®Google Scholar
• Hinnell C, Coulthart MB, Jansen GH, Cashman NR, Lauzon J, Clark A, Costello F, White C, Midha R, Wiebe S, et al. Gerstmann-Straussler-Scheinker disease due to a novel prion protein gene mutation. Neurology 2011; 76(5):485-487; PMID:21282596; http://dx.doi.org/10.1212/WNL.0b013e31820a0ab2
   PubMed Web of Science ®Google Scholar
• Riudavets MA, Sraka MA, Schultz M, Rojas E, Martinetto H, Begué C, de Halac IN, Poleggi A, Equestre M, Pocchiari M, et al. Gerstmann-Straussler-Scheinker syndrome with variable phenotype in a new kindred with PRNP-P102L Mutation. Brain Pathol 2014; 24(2):142-147; PMID:23944754; http://dx.doi.org/10.1111/bpa.12083
   PubMed Web of Science ®Google Scholar
• White A, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, Anstee D, Collinge J, Hawke S. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature; 2003 422(6927):80-3; PMID:12621436; http://dx.doi.org/10.1038/nature01457
   PubMed Web of Science ®Google Scholar
• Perrier V, Solassol J, Crozet C, Frobert Y, Mouton-Gilles C, Grassi J, Lehmann S. Anti-PrP antibodies block PrPsc replication in prion-infected cell cultures by accelerating PrPc degradation. J Neurochem 2004; 89:454-463; PMID:15056288; http://dx.doi.org/10.1111/j.1471-4159.2004.02356.x
   PubMed Web of Science ®Google Scholar
• Korth C, May B, Cohen F, Prusiner S. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci 2001; 98(17):9836-41; PMID:11504948; http://dx.doi.org/10.1073/pnas.161274798
   PubMed Web of Science ®Google Scholar
• Korth C, Peters P, Emerging pharmacotherapies for Creutzfeldt– Jakob disease. Arch Neurol 2006; 63(4):497-501; PMID:16606761; http://dx.doi.org/10.1001/archneur.63.4.497
   PubMed Web of Science ®Google Scholar
• Doh-Ura K, Iwaki T, Caughey B. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 2000; 74(10):4894-4897; PMID:10775631; http://dx.doi.org/10.1128/JVI.74.10.4894-4897.2000
   PubMed Web of Science ®Google Scholar
• Barrett A, Tagliavini F, Forloni G, Salmona M, Colombo L, Luigi D, Limido L, Suardi S, Rossi G, Auvre F, et al. Evaluation of quinacrine treatment for prion diseases. J Virol 2003; 77(15):8462-8469; PMID:12857915; http://dx.doi.org/10.1128/JVI.77.15.8462-8469.2003
   PubMed Web of Science ®Google Scholar
• Assar H, Topakian R, Weis S, Rahimi J, Trenkler J, Höftberger R, Aboulenein-Djamshidian F, Ströbel T, Budka H, Yull H, et al. A case of variably protease-sensitive prionopathy treated with doxycyclin. J Neurol Neurosurg Psychiatry 2015; 86(7):816-8; PMID:25575846; http://dx.doi.org/10.1136/jnnp-2014-309871
   PubMed Web of Science ®Google Scholar
• Haik S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, et al. Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2014; 13(2):150-8; PMID:24411709; http://dx.doi.org/10.1016/S1474-4422(13)70307-7
   PubMed Web of Science ®Google Scholar
• Vetrugno V, Puopolo M, Cardone F, Capozzoli F, Ladogana A, Pocchiari M. The future for treating Creutzfeldt–Jakob disease. Exp Opin Orphan Drugs 2015; 3(1):57-74; http://dx.doi.org/10.1517/21678707.2015.994605
   Web of Science ®Google Scholar
• Forloni G, Artuso V, Roiter I, Morbin M, Tagliavini F. Therapy in prion diseases. Curr Top Med Chem 2013; 13(19):2465-76; PMID:24059336; http://dx.doi.org/10.2174/15680266113136660173
   PubMed Web of Science ®Google Scholar
• Forloni G, Tettamanti M, Lucca U, Albanese Y, Quaglio E, Chiesa R, Erbetta A, Villani F, Redaelli V, Tagliavini F, et al. Preventive study in subjects at risk of fatal familial insomnia: Innovative approach to rare diseases. Prion 2015; 9(2):75-9; PMID:25996399; http://dx.doi.org/10.1080/19336896.2015.1027857
   PubMed Web of Science ®Google Scholar
• Rigter A, Bossers A. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion. J Gen Virol 2005; 86(Pt 9):2627-34; PMID:16099922; http://dx.doi.org/10.1099/vir.0.80901-0
   PubMed Web of Science ®Google Scholar
• Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci U S A 2000; 97(11):5836-41; PMID:10811921; http://dx.doi.org/10.1073/pnas.110523897
   PubMed Web of Science ®Google Scholar
• Priola SA, Vorberg I. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies. Methods Mol Biol 2004; 268:517-40; PMID:15156065
   PubMedGoogle Scholar
• Skinner PJ, Kim HO, Bryant D, Kinzel NJ, Reilly C, Priola SA, Ward AE, Goodman PA, Olson K, Seelig DM. Treatment of prion disease with heterologous prion proteins. PLoS One 2015; 10(7):e0131993; PMID:26134409; http://dx.doi.org/10.1371/journal.pone.0131993
   PubMed Web of Science ®Google Scholar
• Westergard L, Christensen H, Harris D. The cellular prion protein (PrPC): Its physiological function and role in disease. Vet Res 2007; 39(4):629-644.
   Web of Science ®Google Scholar
• Du J, Pan Y, Shi Y, Guo C, Jin X, Sun L, Liu N, Qiao T, Fan D. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int J Cancer 2005; 113(2):213-20; PMID:15386405; http://dx.doi.org/10.1002/ijc.20570
   PubMed Web of Science ®Google Scholar
• Vey M, Pilkuhn S, Wille S, Nixon R, DeArmond S, Smart E, Taraboulos A, Prusiner S. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. PNAS 1996; 93(25):14945-14949; PMID:8962161; http://dx.doi.org/10.1073/pnas.93.25.14945
   PubMed Web of Science ®Google Scholar
• Alfonso DS, Adriana Z, Philippe D. Structural and hydration properties of the partially Unfolded States of the prion protein. Biophys J 2007; 93(4):1284-92; PMID:17483173; http://dx.doi.org/10.1529/biophysj.107.108613
   PubMed Web of Science ®Google Scholar
• Mehrpour M, Codogno P, From physiology to cancer biology. Cancer Lett 2010; 290(1):23; http://dx.doi.org/10.1016/j.canlet.2009.07.009
   Web of Science ®Google Scholar
• Linden R, Martins V, Prado M, Cammarota M, Izquiero I, Brentani R. Physiology of the prion protein. Physiol Rev 2008; 88:673-728; PMID:18391177; http://dx.doi.org/10.1152/physrev.00007.2007
   PubMed Web of Science ®Google Scholar
• Stewart R, Harris D. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J Biol Chem 2003; 278:45960-45968; PMID:12933795; http://dx.doi.org/10.1074/jbc.M307833200
   PubMed Web of Science ®Google Scholar
• Welker E, Raymond LD, Scheraga HA, Caughey B. Intramolecular versus intermolecular disulfide bonds in prion proteins. J Biol Chem 2002 277(36):33477-81; PMID:12082114; http://dx.doi.org/10.1074/jbc.M204273200
   PubMed Web of Science ®Google Scholar
• Hooper N. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc F Trans 2005; 33:335-338; http://dx.doi.org/10.1042/BST0330335
   PubMed Web of Science ®Google Scholar
• Mange A, Beranger F, Peoc’h K, Onodera T, Frobert Y, Lehmann S. Alpha- and beta-cleavages of the amino-terminus of the cellular prion protein. Biol Cell 2004; 96:125-132; PMID:15050367; http://dx.doi.org/10.1016/j.biolcel.2003.11.007
   PubMed Web of Science ®Google Scholar
• Vincent B, Paitel E, Frobert Y, Lehmann S, Grassi J, Checler F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem 2000; 275:35612-35616; PMID:10952979; http://dx.doi.org/10.1074/jbc.M004628200
   PubMed Web of Science ®Google Scholar
• Pan K, Stahl N, Prusiner S. Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci 1992; 1:1343-1352; PMID:1363897; http://dx.doi.org/10.1002/pro.5560011014
   PubMed Web of Science ®Google Scholar
• Jimenez-Huete A, Lievens P, Vidal R, Piccardo P, Ghetti B, Tagliavini F, Frangione B, Prelli F. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 1998; 153:1561-1572; PMID:9811348; http://dx.doi.org/10.1016/S0002-9440(10)65744-6
   PubMed Web of Science ®Google Scholar
• Nieznanski K, Nieznanska H, Skowronek K, Osiecka K, Stepkowski D. Direct interaction between prion protein and tubulin. Biochem Biophys Res Commun 2005; 334:403-411; PMID:16004966; http://dx.doi.org/10.1016/j.bbrc.2005.06.092
   PubMed Web of Science ®Google Scholar
• Watt N, Taylor D, Gillott A, Thomas D, Perera W, Hooper N. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J Biol Chem 2005; 280:35914-35921; PMID:16120605; http://dx.doi.org/10.1074/jbc.M507327200
   PubMed Web of Science ®Google Scholar
• Taraboulos A, Raeber A, Borchelt D, Serban D, Prusiner S. Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell 1992; 3:851-863; PMID:1356522; http://dx.doi.org/10.1091/mbc.3.8.851
   PubMed Web of Science ®Google Scholar
• Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, Hooper NM. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 2009; 284(34):22590-600; PMID:19564338; http://dx.doi.org/10.1074/jbc.M109.032599
   PubMed Web of Science ®Google Scholar
• Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D, Jorissen E, Petrowitz B, Bartsch U, De Strooper B, et al. Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener 2011; 6:36; PMID:21619641; http://dx.doi.org/10.1186/1750-1326-6-36
   PubMed Web of Science ®Google Scholar
• Stahl N, Baldwin MA, Burlingame AL, Prusiner SB. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 1990; 29(38):8879-84; PMID:1980209; http://dx.doi.org/10.1021/bi00490a001
   PubMed Web of Science ®Google Scholar
• Parizek P, Roeckl C, Weber J, Flechsig E, Aguzzi A, Raeber AJ. Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells. J Biol Chem 2001; 276(48):44627-32; PMID:11571302; http://dx.doi.org/10.1074/jbc.M107458200
   PubMed Web of Science ®Google Scholar
• Tagliavini F, Prelli F, Porro M, Salmona M, Bugiani O, Frangione B. A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun 1992; 184(3):1398-404; PMID:1375461; http://dx.doi.org/10.1016/S0006-291X(05)80038-5
   PubMed Web of Science ®Google Scholar
• Parkin ET, Watt NT, Turner AJ, Hooper NM. Dual mechanisms for shedding of the cellular prion protein. J Biol Chem 2004; 279(12):11170-8; PMID:14711812; http://dx.doi.org/10.1074/jbc.M312105200
   PubMed Web of Science ®Google Scholar
• Kubosaki A, Yusa S, Nasu Y, Nishimura T, Nakamura Y, Saeki K, Matsumoto Y, Itohara S, Onodera T. Distribution of cellular isoform of prion protein in T lymphocytes and bone marrow, analyzed by wild-type and prion protein gene-deficient mice. Biochem Biophys Res Commun 2001; 282:103-107; PMID:11263978; http://dx.doi.org/10.1006/bbrc.2001.4538
   PubMed Web of Science ®Google Scholar
• Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, Schumann P, Windl O, Brose N, Kretzscmar H. Evidence of presynaptic location and function of the prion protein. J Neuroscience 1999; 19(20):8866-75; PMID:10516306
   PubMed Web of Science ®Google Scholar
• Collinge J, Whittinton M, Sidle K, Smith C, Palmer M, Clarke, Jeffers J. Prion Protein is necessary for normal synaptic function. Nature 1994; 370:295-7; PMID:8035877; http://dx.doi.org/10.1038/370295a0
   PubMed Web of Science ®Google Scholar
• Lledo P, Tremblay P, DeArmond S, Prusiner S, Nicoll R. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc Natl Acad Sci USA 1996; 93:2403-7; PMID:8637886; http://dx.doi.org/10.1073/pnas.93.6.2403
   PubMed Web of Science ®Google Scholar
• Jackson G, Nurray I, Hosszu, Gibbs N, Waltho J, Clarke A, Collinge J. Location and properties of metal binding sites on the human prion protein. Prc Natl Acad Sci USA 2001; 98(15):8531-5; http://dx.doi.org/10.1073/pnas.151038498
   PubMed Web of Science ®Google Scholar
• Walter ED, Stevens DJ, Visconte MP, Millhauser GL. The prion protein is a combined zinc and copper binding protein: Zn2+ alters the distribution of Cu2+ coordination modes. J Am Chem Soc 2007; 129(50):15440-1; PMID:18034490; http://dx.doi.org/10.1021/ja077146j
   PubMed Web of Science ®Google Scholar
• Walter ED, Stevens DJ, Spevacek AR, Visconte MP, Dei Rossi A, Millhauser GL. Copper binding extrinsic to the octarepeat region in the prion protein. Curr Protein Pept Sci 2009; 10(5):529-35; PMID:19538144; http://dx.doi.org/10.2174/138920309789352056
   PubMed Web of Science ®Google Scholar
• Kretzschmar H, Tings T, Madlung A, Giese A, Herms J. Function of PrPc as a copper binding protein at the synapse. Arch Virol Suppl 2000; 1:239-49.
   Google Scholar
• Pauly P, Harris D. Copper stimulates endocytosis of the prion protein. J Biol Chem 1998; 273:33107-10; PMID:9837873; http://dx.doi.org/10.1074/jbc.273.50.33107
   PubMed Web of Science ®Google Scholar
• Lasmezas C. Putative Functions of PrPc. Br Med Bulletin 2003; 66:61-70; http://dx.doi.org/10.1093/bmb/66.1.61
   PubMed Web of Science ®Google Scholar
• Qin, K, Zhao L, Ash R, McDonough W, Zhao R. ATM mediated transcriptional elevation of prion in response to copperinduced oxidative stress. J Biol Chem 2009; 284:4582-4593; PMID:19064990; http://dx.doi.org/10.1074/jbc.M808410200
   PubMed Web of Science ®Google Scholar
• Prcina M, Kontsekova E, Novak M. Prion protein prevents heavy metals overloading of cells and thus protects them against their toxicity. Acta Virol 2015; 59(2):179-84; PMID:26104335; http://dx.doi.org/10.4149/av_2015_02_179
   PubMed Web of Science ®Google Scholar
• Vassallo N, Herms J, Behrens C, Krebs B, Saeki K, Onodera T, Windl O, Kretzschmar HA. Activation of phosphatidylinositol 3-kinase by cellular prion protein and its role in cell survival. Biochem Biophys Res Commun 2005; 332(1):75-82; PMID:15896301; http://dx.doi.org/10.1016/j.bbrc.2005.04.099
   PubMed Web of Science ®Google Scholar
• Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. Cellular prion protein transduces neuroprotective signals. Embo J 2002; 21(13):3317-26; PMID:12093733; http://dx.doi.org/10.1093/emboj/cdf324
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000; 289(5486):1925-8; PMID:10988071; http://dx.doi.org/10.1126/science.289.5486.1925
   PubMed Web of Science ®Google Scholar
• Mattei V, Garofalo T, Misasi R, Circella A, Manganelli V, Lucania G, Pavan A, Sorice M. Prion protein is a component of the multimolecular signalling complex involved in T cell activation. FEBS Lett 2004; 560(1-3):14-8; PMID:14987990; http://dx.doi.org/10.1016/S0014-5793(04)00029-8
   PubMed Web of Science ®Google Scholar
• Martinez D, Lopez-Bravo M, Metharom P, Ardavin C, Aucouturier P. Prion protein expression by mouse dendritic cells is restricted to the nonplasmacytoid subsets and correlates with the maturation state. J Immunol 2006; 177(9):6137-42; PMID:17056541; http://dx.doi.org/10.4049/jimmunol.177.9.6137
   PubMed Web of Science ®Google Scholar
• McCulloch L, Brown KL, Mabbott NA. Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function. Immunology 2013; 138(3):246-57; PMID:23121447; http://dx.doi.org/10.1111/imm.12031
   PubMed Web of Science ®Google Scholar
• de Almeida CJ, Chiarini LB, da Silva JP, E Silva PM, Martins MA, Linden R. The cellular prion protein modulates phagocytosis and inflammatory response. J Leukoc Biol 2005; 77(2):238-46; PMID:15539455; http://dx.doi.org/10.1189/jlb.1103531
   PubMed Web of Science ®Google Scholar
• Bainbridge J, Walker K. The normal cellular form of prion protein modulates T cell responses. Immunol Lett 2005; 96(1):147-50; PMID:15585317; http://dx.doi.org/10.1016/j.imlet.2004.08.006
   PubMed Web of Science ®Google Scholar
• Seong YJ, Sung PS, Jang YS, Choi YJ, Park BC, Park SH, Park YW, Shin EC. Activation of human natural killer cells by the soluble form of cellular prion protein. Biochem Biophys Res Commun 2015; 464(2):512-8; PMID:26159919; http://dx.doi.org/10.1016/j.bbrc.2015.06.172
   PubMed Web of Science ®Google Scholar
• Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp H, DeArmond S, Prusiner S, Aguet M, Weissmann C. Normal development and behaviour of mice lacking the neuronal cell surface PrP protein. Nature 1992; 356:577-582; PMID:1373228; http://dx.doi.org/10.1038/356577a0
   PubMed Web of Science ®Google Scholar
• Kuwahara C, Takeuchi A, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, et al. Prions prevent neuronal cell-line death. Nature 1999; 400(6741):225-6; PMID:10421360; http://dx.doi.org/10.1038/22241
   PubMed Web of Science ®Google Scholar
• Roucou X, Gains M, LeBlanc A. Neuroprotective functions of prion protein. J Neurosci Res 2004; 75(2):153-61; PMID:14705136; http://dx.doi.org/10.1002/jnr.10864
   PubMed Web of Science ®Google Scholar
• Bounhar Y, Zhang Y, Goodyer C, LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 2001; 276(42):39145-9; PMID:11522774; http://dx.doi.org/10.1074/jbc.C100443200
   PubMed Web of Science ®Google Scholar
• Martinou J, Green D. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2001; 2(1):63-7; PMID:11413467; http://dx.doi.org/10.1038/35048069
   PubMed Web of Science ®Google Scholar
• Roucou X, LeBlanc A. Cellular prion protein neuroprotective function: implications in prion diseases. J Mol Med 2005; 83:3-11; PMID:15645198; http://dx.doi.org/10.1007/s00109-004-0605-5
   PubMed Web of Science ®Google Scholar
• Collinge J, Whittington M, Sidle K, Smith C, Palmer M, Clarke A, Jefferys J. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295-297; PMID:8035877; http://dx.doi.org/10.1038/370295a0
   PubMed Web of Science ®Google Scholar
• Colling S, Collinge J, Jefferys J. Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 1996; 209:49-52; PMID:8734907; http://dx.doi.org/10.1016/0304-3940(96)12596-9
   PubMed Web of Science ®Google Scholar
• Curtis J, Errington M, Bliss T, Voss K, MacLeod N. Age dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiol Dis 2003; 13:55-62; PMID:12758067; http://dx.doi.org/10.1016/S0969-9961(03)00017-2
   PubMed Web of Science ®Google Scholar
• Mallucci GR, Ratte´ S, Asante EA, Linehan J, Gowland I, Jefferys JGR, Collinge J. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002; 21:202-210; PMID:11823413; http://dx.doi.org/10.1093/emboj/21.3.202
   PubMed Web of Science ®Google Scholar
• Manson JC, Hope J, Clarke AR, Johnston A, Black C, MacLeod N. PrP gene dosage and long term potentiation. Neurodegeneration 1995; 4:113-114; PMID:7600180; http://dx.doi.org/10.1006/neur.1995.0014
   PubMedGoogle Scholar
• Criado J, Sanchez-Alavez M, Conti B, Giacchino J, Wills D, Henriksen S, Race R, Manson J, Chesebro B, Oldstone M. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 2005; 19:255-265; PMID:15837581; http://dx.doi.org/10.1016/j.nbd.2005.01.001
   PubMed Web of Science ®Google Scholar
• Lobao-Soares B, Walz R, Carlotti Jr. C, Sakamoto A, Calvo F, Terzian A, da Silva J, Wichert-Ana L, Coimbra N, Bianchin M. Cellular prion protein regulates the motor behaviour performance and anxiety-induced responses in genetically modified mice. Behav. Brain Res 2007; 183:87-94; PMID:17618696; http://dx.doi.org/10.1016/j.bbr.2007.05.027
   PubMed Web of Science ®Google Scholar
• Mange A, Milhavet O, Umlauf D, Harris D, Lehmann S. PrP dependent cell adhesion in N2a neuroblastoma cells. FEBS Lett 2002; 514(2-3):159-62; PMID:11943143; http://dx.doi.org/10.1016/S0014-5793(02)02338-4
   PubMed Web of Science ®Google Scholar
• Crossin K, Krushel L. Cellular signaling by neural cell adhesion molecules of the immunoglobulin superfamily. Dev Dyn 2000; 218:260-279; PMID:10842356; http://dx.doi.org/10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9
   PubMed Web of Science ®Google Scholar
• Ronn L, Berezin V, Bock E. The neural cell adhesion molecule in synaptic plasticity and ageing. Int J Dev Neurosci 2000; 18:193-199; PMID:10715574; http://dx.doi.org/10.1016/S0736-5748(99)00088-X
   PubMed Web of Science ®Google Scholar
• Schachner M. Neural recognition molecules and synaptic plasticity. Curr Opin Cell Biol 1997; 9:627-634; PMID:9330865; http://dx.doi.org/10.1016/S0955-0674(97)80115-9
   PubMed Web of Science ®Google Scholar
• Santuccione A, Sytnyk V, Leshchyns'ka I, Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 2005; 169(2):341-54; PMID:15851519; http://dx.doi.org/10.1083/jcb.200409127
   PubMed Web of Science ®Google Scholar
• Chen S, Mange A, Dong L, Lehmann S, Schachner M. Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci 2003; 22(2):227-33; PMID:12676532; http://dx.doi.org/10.1016/S1044-7431(02)00014-3
   PubMed Web of Science ®Google Scholar
• Liang J, Pan YL, Ning XX, Sun LJ, Lan M, Hong L, Du JP, Liu N, Liu CJ, Qiao TD, et al. Overexpression of PrPC and its antiapoptosis function in gastric cancer. Tumour Biol 2006; 27(2):84-91; PMID:16582585; http://dx.doi.org/10.1159/000092488
   PubMed Web of Science ®Google Scholar
• Liang J, Pan Y, Zhang D, Guo C, Shi Y, Wang J, Chen Y, Wang X, Liu J, Guo X, et al. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J 2007; 21(9):2247-56; PMID:17409275; http://dx.doi.org/10.1096/fj.06-7799com
   PubMed Web of Science ®Google Scholar
• Han H, Bearss D, Browne W, Calaluce R, Nagle R, Hoff D. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002; 62:2890-2896; PMID:12019169
   PubMed Web of Science ®Google Scholar
• Li C, Yu S, Nakamura F, Yin S, Xu J, Petrolla AA, Singh N, Tartakoff A, Abbott DW, Xin W, et al. Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest 2009; 119(9):2725-36; PMID:19690385; http://dx.doi.org/10.1172/JCI39542
   PubMed Web of Science ®Google Scholar
• Antonacopoulou AG, Grivas PD, Skarlas L, Kalofonos M, Scopa CD, Kalofonos HP. POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance? Anticancer Res 2008; 28(2B):1221-7; PMID:18505059
   PubMed Web of Science ®Google Scholar
• Antonacopoulou AG, Palli M, Marousi S, Dimitrakopoulos FI, Kyriakopoulou U, Tsamandas AC, Scopa CD, Papavassiliou AG, Kalofonos HP. Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer. Mol Carcinog 2010; 49(7):693-9; PMID:20564346
   PubMed Web of Science ®Google Scholar
• Zhao Y, You H, Liu F, An H, Shi Y, Yu Q, Fan D. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002; 185(2):211-8; PMID:12169395; http://dx.doi.org/10.1016/S0304-3835(02)00264-1
   PubMed Web of Science ®Google Scholar
• Wang Q, Qian J, Wang F, Ma Z. Cellular prion protein accelerates colorectal cancer metastasis via the Fyn-SP1-SATB1 axis. Oncol Rep 2012; 28(6):2029-34; PMID:22972305
   PubMed Web of Science ®Google Scholar
• Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452(7184):187-93; PMID:18337816; http://dx.doi.org/10.1038/nature06781
   PubMed Web of Science ®Google Scholar
• Kolch W. Meaningful relationships: The Regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000; 351:289-305; PMID:11023813; http://dx.doi.org/10.1042/bj3510289
   PubMed Web of Science ®Google Scholar
• Duffy M, Maguire T, Hill A, McDermott E, O’Higgins N, Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2000; 2:252-257; PMID:11250717; http://dx.doi.org/10.1186/bcr65
   PubMed Web of Science ®Google Scholar
• Popova SN, Tarvainen I, Capellari S, Parchi P, Hannikainen P, Pirinen E, Haapasalo H, Alafuzoff I. Divergent clinical and neuropathological phenotype in a Gerstmann-Straussler-Scheinker P102L family. Acta Neurol Scand 2012; 126(5):315-323; PMID:22211828; http://dx.doi.org/10.1111/j.1600-0404.2011.01628.x
   PubMed Web of Science ®Google Scholar
• Burns A, Iliffe S. Alzheimer's disease. 2009; 338.
   Google Scholar
• Peters C, Espinoza MP, Gallegos S, Opazo C, Aguayo LG. Alzheimer's Abeta interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity. Neurobiol Aging 2015; 36(3):1369-77; PMID:25599875; http://dx.doi.org/10.1016/j.neurobiolaging.2014.11.019
   PubMed Web of Science ®Google Scholar
• Aimi T, Suzuki K, Hoshino T, Mizushima T. Dextran sulfate sodium inhibits amyloid-beta oligomer binding to cellular prion protein. J Neurochem 2015; 134(4):611-7; PMID:25963375; http://dx.doi.org/10.1111/jnc.13166
   PubMed Web of Science ®Google Scholar
• Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006; 63(5):530-8; PMID:16651510; http://dx.doi.org/10.1001/archpsyc.63.5.530
   PubMed Web of Science ®Google Scholar
• Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, Duara R, Kukull WA, Chui H, Edeki T, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol 2003; 60(5):753-9; PMID:12756140; http://dx.doi.org/10.1001/archneur.60.5.753
   PubMed Web of Science ®Google Scholar
• Thompson A, MacKay A, Rudge P, Lukic A, Porter MC, Lowe J, Collinge J, Mead S. Behavioral and psychiatric symptoms in prion disease. Am J Psychiatry 2014; 171(3):265-74; PMID:24585329; http://dx.doi.org/10.1176/appi.ajp.2013.12111460
   PubMed Web of Science ®Google Scholar
• Gadotti VM, Bonfield SP, Zamponi GW. Depressive-like behaviour of mice lacking cellular prion protein. Behav Brain Res 2012; 227(2):319-23; PMID:21439331; http://dx.doi.org/10.1016/j.bbr.2011.03.012
   PubMed Web of Science ®Google Scholar
• Beckman D, Santos LE, Americo TA, Ledo JH, de Mello FG, Linden R. Prion protein modulates monoaminergic systems and depressive-like behavior in mice. J Biol Chem 2015; 290(33):20488-98; PMID:26152722
   PubMed Web of Science ®Google Scholar
• Ledo JH, Azevedo EP, Clarke JR, Ribeiro FC, Figueiredo CP, Foguel D, De Felice FG, Ferreira ST. Amyloid-beta oligomers link depressive-like behavior and cognitive deficits in mice. Mol Psychiatry 2013; 18(10):1053-4; PMID:23183490; http://dx.doi.org/10.1038/mp.2012.168
   PubMed Web of Science ®Google Scholar